SANDRA ABRAHAMIAN: Open Payments
NPI 1528418027 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 12 payments from 6 companies in 2025. Trend: 2023 $994 · 2024 $1,595 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $236 |
| Janssen Pharmaceuticals, Inc | 1 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| ABBVIE INC. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
Products named: CAPLYTA, INVEGA SUSTENNA, REXULTI, VRAYLAR, COBENFY, INGREZZA.
Industry payments across MA — which companies pay providers there.
